Update from the Long-Term Follow-Up Phase of ReNeu: A Pivotal Phase 2b Trial of Mirdametinib in Adults and Children with Neurofibromatosis Type 1-Associated Symptomatic Plexiform Neurofibroma
Neuropediatrics | April 27, 2026 | Volume: 57 | Issue: No issue available | Pages: No page available
10.1055/s-0046-1822861